Mofezolac


CAS No. : 78967-07-4

78967-07-4
Price and Availability of CAS No. : 78967-07-4
Size Price Stock
5mg $40 In-stock
10mg $72 In-stock
25mg $150 In-stock
50mg $250 In-stock
100mg $400 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-120824
M.Wt: 339.34
Formula: C19H17NO5
Purity: >98 %
Solubility: DMSO : 100 mg/mL (ultrasonic)
Introduction of 78967-07-4 :

Mofezolac, a non-steroidal anti-inflammatory drug (NSAID), is a selective, reversible and orally active COX-1 inhibitor with an IC50 of 1.44 nM. Mofezolac shows weak inhibitory activity on COX-2 (IC50 of 447 nM). Mofezolac can relieve pain and has anti-inflammatory activities[1]. In Vitro: Mofezolac inhibits platelet aggregation with an IC50 of 0.45 μM in human platelet rich plasma (hPRP) assay[2].
Mofezolac slightly increase Bortezomib cytotoxic effect on multiple myeloma (MM) cell lines (NCI-H929 and RPMI-8226) and affects MM cell cycle and apoptosis when co-administered with the proteasome inhibitor Bortezomib[2]. In Vivo: Mofezolac (1-30 mg/kg; oral administration; once) treatment results in the suppression of writhing induced by the intraperitoneal injection of phenyl-p-benzoquinone in mice[1].

Your information is safe with us.